000 01376 a2200361 4500
005 20250516184624.0
264 0 _c20140821
008 201408s 0 0 eng d
022 _a1532-866X
024 7 _a10.1016/j.semarthrit.2013.05.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFaruque, Labib I
245 0 0 _aA systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout.
_h[electronic resource]
260 _bSeminars in arthritis and rheumatism
_cDec 2013
300 _a367-75 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aAllopurinol
_xadverse effects
650 0 4 _aFebuxostat
650 0 4 _aGout
_xblood
650 0 4 _aGout Suppressants
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHyperuricemia
_xblood
650 0 4 _aThiazoles
_xadverse effects
650 0 4 _aTreatment Outcome
650 0 4 _aUric Acid
_xblood
700 1 _aEhteshami-Afshar, Arash
700 1 _aWiebe, Natasha
700 1 _aTjosvold, Lisa
700 1 _aHomik, Joanne
700 1 _aTonelli, Marcello
773 0 _tSeminars in arthritis and rheumatism
_gvol. 43
_gno. 3
_gp. 367-75
856 4 0 _uhttps://doi.org/10.1016/j.semarthrit.2013.05.004
_zAvailable from publisher's website
999 _c23355688
_d23355688